A medication used in a clinical trail is showing some promising results for people with hypertrophic cardiomyopathy -- or HCM for short. The disease, which causes abnormal thickening of the heart muscle, affects between 15 and 20 million people worldwide.
© 2024, KPVM-TV Channel 25
All material found on www.kpvm.tv is copyrighted.
No material may be reproduced or reused without explicit permission from KPVM-TV Channel 25.
KPVM-TV, Inc. is an equal opportunity employer. View EEO report here.
Built on Envisionwise Technology. Administrator Login
